Phase 1 biotech developing a vaccine for recurrent UTIs and small molecules for cancers.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 11/06/2023 |
Offer Price | |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 2.8 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range $8.00 - $10.00 | |
Offer Shares (mm) | 2.8 |
Deal Size ($mm) | $25 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
ThinkEquity |
Company Data | |
---|---|
Headquarters | St. Louis, MO, United States |
Founded | 2012 |
Employees at IPO | 11 |
Website www.sequoiavaccines.com |